Coyle Financial Counsel’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Coyle Financial Counsel's BMY Position: Q3 2018 in Review
Coyle Financial Counsel sold out of Bristol-Myers Squibb (BMY) in Q3 2018, closing a stake of 324 shares — an estimated $18K sold.
Coyle Financial Counsel first reported a position in BMY in Q1 2018 and held it in 2 quarters. The position peaked at $23K in Q1 2018. 1,730 funds tracked by Wall St. Rank hold BMY as of Q3 2018.
- Coyle Financial Counsel reported no remaining Bristol-Myers Squibb position as of Q3 2018 after selling out during the quarter.
- Coyle Financial Counsel sold 324 Bristol-Myers Squibb shares in Q3 2018, an estimated $18K.
- Coyle Financial Counsel first reported a position in Bristol-Myers Squibb in Q1 2018 and held it in 2 quarters.
- Coyle Financial Counsel's Bristol-Myers Squibb position peaked at $23K in Q1 2018.
- 1,730 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2018.
Based on Coyle Financial Counsel's 13F filing for Q3 2018, filed 13 Nov 2018.